FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Bromocriptine Mesylate Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism; Neurology

Expand all

Mylan Pharmaceuticals Inc. (New 07/10/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
2.5 mg, 30 count bottle (NDC 0378-2042-93) 07/10/2018 The discontinuation of this product is a business decision. The capsules will continue to be available.
2.5 mg, 100 count bottle (NDC 0378-2042-01) 07/10/2018 The discontinuation of this product is a business decision. The capsules will continue to be available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English